Clinical efficacy of Qianmitong in the treatment of Chronic prostatitis with qi-stagnancy and blood stasis Syndrome

Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Those who meet the diagnostic criteria of chronic prostatitis can be used as test cases;
•2. Age between 18-50 years old;
•3. Those who have received treatment stop using all related drugs for the treatment of prostatitis for more than 2 weeks;
•4. Volunteer to participate in the treatment and sign the trial informed consent.

•1. Complicated with abnormal development of the genitourinary system;
•2. Accompanied by diseases such as urinary tract infection and prostate tuberculosis;
•3. Accompanied by prostate hyperplasia, prostate tumor, severe neurosis and other diseases;
•4. Other diseases in the lower abdomen, perineum, lumbosacral and other parts with local pain as the main manifestation have not been ruled out;
•5. Combined with severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, and mental illness;
•6. Other situations where it is not possible to participate in the research in the whole process.

发起方

Hospital of Chengdu University of Traditional Chinese Medicine